Dual Treatment May Boost Efficacy in Chronic Migraine ...Middle East

For patients with chronic migraine, dual therapy with anti-CGRP mAbs and onaotulinumtoxinA significantly decreased the number of monthly migraine days compared with single therapy with either drug. Medscape Medical News

Hence then, the article about dual treatment may boost efficacy in chronic migraine was published today ( Thursday 29/06/2023 - 10:13 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dual Treatment May Boost Efficacy in Chronic Migraine )

Also on site :

• Ukraine will try “to get some concessions” from Trump at meeting
• Numbrix 9 - December 28
• Getting hired in 2026 is all about your ‘microcredentials’ says CEO of $1.3 billion learning platform—this is what he tells Gen Z to focus on